Jazz Pharmaceuticals JAZZ Interest Paid, Excluding Capitalized Interest, Operating Activity
Interest Paid, Excluding Capitalized Interest, Operating Activity at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's interest paid, excluding capitalized interest, operating activity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's interest paid, excluding capitalized interest, operating activity?
- Jazz Pharmaceuticals (JAZZ) reported interest paid, excluding capitalized interest, operating activity of $62.14M in Q4 2025.
- How has Jazz Pharmaceuticals's interest paid, excluding capitalized interest, operating activity changed year-over-year?
- Jazz Pharmaceuticals's interest paid, excluding capitalized interest, operating activity decreased by 21.0% year-over-year, from $78.71M to $62.14M.
- What is the long-term trend for Jazz Pharmaceuticals's interest paid, excluding capitalized interest, operating activity?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's interest paid, excluding capitalized interest, operating activity has grown at a 15.8% compound annual growth rate (CAGR), from $138.27M to $248.55M.